Non-ownership Filings
| Cancellation of admission to trading on AIM | Feb. 15, 2023 |
| Update on Administration and Suspension of Trading | Dec. 30, 2022 |
| Blautix Phase II Clinical Trial Results Published | Nov. 16, 2022 |
| MRx0518 SITC 2022 poster presentations | Nov. 10, 2022 |
| MRx0518 poster presentations at SITC 2022 | Oct. 05, 2022 |
| Update on Suspension of Trading on AIM | Sep. 29, 2022 |
| Publication of preclinical autism research | Aug. 24, 2022 |
Ownership Update Filings
| Holding(s) in Company | Mar. 24, 2022 |
| Holding(s) in Company | Mar. 21, 2022 |
| Holding(s) in Company | Feb. 24, 2022 |
| Holding(s) in Company | Jan. 25, 2022 |
| Holding(s) in Company | Jan. 06, 2022 |
| Grant of Options | Jan. 04, 2022 |
| Holding(s) in Company | Dec. 07, 2021 |